T1	Participants 253 323	healthy subjects using a pharmacokinetic/pharmacodynamic (PK/PD) model
T2	Participants 75 134	indirect pharmacological response model in healthy subjects
T3	Participants 404 604	0 healthy Chinese subjects (4 groups of 10 subjects each, placebo 4:1 ratio) who received infusions of uricase (single doses of 0.1, 0.2, and 0.3 mg/kg; multiple doses of 0.2 mg·kg(-1)·d(-1) for 7 d).
T4	Participants 403 405	40
T5	Participants 1423 1479	Infusions of uricase were well tolerated in all subjects
T6	Participants 1522 1573	effective dose to be 0.1 mg/kg in healthy subjects.
